TICAGRELOR S.K. 60 MG
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
TICAGRELOR
Available from:
K.S.KIM INTERNATIONAL (SK- PHARMA) LTD., ISRAEL
ATC code:
B01AC24
Pharmaceutical form:
FILM COATED TABLETS
Composition:
TICAGRELOR 60 MG
Administration route:
PER OS
Prescription type:
Required
Manufactured by:
ADALVO LIMITED, MALTA
Therapeutic area:
TICAGRELOR
Therapeutic indications:
Ticagrelor S.K., co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with - acute coronary syndromes (ACS) or- a history of myocardial infarction (MI) and a high risk of developing an atherothrombotic event.Limitations of use: 90 mg twice daily during the first year after an ACS event followed by 60 mg twice daily for additional 2 years.
Authorization date:
2023-08-27
